학술논문
CSI clinical practice guidelines for dyslipidemia management: Executive summary.
Document Type
Academic Journal
Author
Sawhney JP; Sir Ganga Ram Hospital, New Delhi, India. Electronic address: jpssawhney@yahoo.com.; Ramakrishnan S; All India Institute of Medical Sciences, Delhi, India. Electronic address: ramaaiims@gmail.com.; Madan K; Sir Ganga Ram Hospital, New Delhi, India. Electronic address: kushalmadan@gmail.com.; Ray S; Advanced Medical Research Institute (Dhakuria), Kolkata, West Bengal, India. Electronic address: drsaumitra@yahoo.co.in.; Jayagopal PB; Lakshmi Hospital, Chittur Road, Palakkad, Kerala, India. Electronic address: jaigopallakshmi@gmail.com.; Prabhakaran D; Centre for Chronic Disease Control, New Delhi, India. Electronic address: dprabhakaran@ccdcindia.org.; Nair T; PRS Hospital, Trivandrum, Kerala, India. Electronic address: tinynair@gmail.com.; Zachariah G; Mother Heart Care, Mother Hospital, Thrissur, Kerala, India. Electronic address: geevarzachariah@gmail.com.; Jain P; Fortis Escorts Heart Institute, New Delhi, India. Electronic address: dpn2005@gmail.com.; Dalal J; Kokilaben Hospital, Mumbai, Maharashtra, India. Electronic address: jjdalal@hotmail.com.; Radhakrishnan S; Amrita Hospital, Greater Faridabad, Haryana, India. Electronic address: Samurai43@yahoo.com.; Chopra A; Fortis Escorts Hospital, Amritsar, India. Electronic address: akchopra1@rediffmail.com.; Kalra S; Bharti Hospital, Karnal, India. Electronic address: brideknl@gmail.com.; Mehta A; Sir Ganga Ram Hospital, New Delhi, India. Electronic address: drashwanimehta@gmail.com.; Pancholia AK; Arihant Hospital, Indore, India. Electronic address: drpancholia@gmail.com.; Kabra NK; Gandhi Medical College, Hyderabad, India. Electronic address: nitink99@yahoo.com.; Kahali D; BM Birla Heart Institute, Kolkata, India. Electronic address: dhiman.kahali@gmail.com.; Ghose T; Fortis Flt Lt Rajan Dhall Hospital, New Delhi, India. Electronic address: ghosetapan@gmail.com.; Yadav S; All India Institute of Medical Sciences, Delhi, India. Electronic address: drsatyaviryadav87@gmail.com.; Kerkar P; Seth G.S. Medical College & KEM Hospital, Mumbai, India. Electronic address: prafullakerkar@gmail.com.; Yadav A; Sir Ganga Ram Hospital, New Delhi, India. Electronic address: Ajay.vascular@gmail.com.; Roy D; NH- Rabindranath Tagore International Institute of Cardiac Sciences, Kolkata, India. Electronic address: debroy67@ymail.com.; Das MK; B.M. Birla Heart Research Centre and the Calcutta Medical Research Institute (CMRI), Kolkata, India. Electronic address: drmkdas2001@yahoo.co.in.; Bang VH; Lilavati Hospital and Research centre, Mumbai, Maharashtra, India. Electronic address: shivvhb@yahoo.com.; Rath PC; Apollo Hospital, Jubilee Hill, Hyderabad, India. Electronic address: drpcrath@hotmail.com.; Sinha DP; ILS Hospital, Dumdum, Kolkata, India. Electronic address: drdpsinha@gmail.com.; Banerjee PS; Manipal Hospital, Salt Lake, Kolkata, India. Electronic address: drpartha76@gmail.com.; Yadav R; All India Institute of Medical Sciences, Delhi, India. Electronic address: Rakeshyadav123@yahoo.com.; Gupta R; Eternal Heart Care Centre & Research Institute, Jaipur, India. Electronic address: rajeevgg@gmail.com.
Source
Publisher: Elsevier Country of Publication: India NLM ID: 0374675 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2213-3763 (Electronic) Linking ISSN: 00194832 NLM ISO Abbreviation: Indian Heart J Subsets: MEDLINE
Subject
Language
English
Abstract
Dyslipidemias are the most important coronary artery disease (CAD) risk factor. Proper management of dyslipidemia is crucial to control the epidemic of premature CAD in India. Cardiological Society of India strived to develop consensus-based guidelines for better lipid management for CAD prevention and treatment. The executive summary provides a bird's eye-view of the 'CSI: Clinical Practice Guidelines for Dyslipidemia Management' published in this issue of the Indian Heart Journal. The summary is focused on the busy clinician and encourages evidence-based management of patients and high-risk individuals. The summary has serialized various aspects of lipid management including epidemiology and categorization of CAD risk. The focus is on management of specific dyslipidemias relevant to India-raised low density lipoprotein (LDL) cholesterol, non-high density lipoprotein cholesterol (non-HDL-C), apolipoproteins, triglycerides and lipoprotein(a). Drug therapies for lipid lowering (statins, non-statin drugs and other pharmaceutical agents) and lifestyle management (dietary interventions, physical activity and yoga) are summarized. Management of dyslipidemias in oft-neglected patient phenotypes-the elderly, young and children, and patients with comorbidities-stroke, peripheral arterial disease, kidney failure, posttransplant, HIV (Human immunodeficiency virus), Covid-19 and familial hypercholesterolemia is also presented. This consensus statement is based on major international guidelines (mainly European) and expert opinion of lipid management leaders from India with focus on the dictum: earlier the better, lower the better, longer the better and together the better. These consensus guidelines cannot replace the individual clinician judgement who remains the sole arbiter in management of the patient.
(Copyright © 2023 Cardiological Society of India. Published by Elsevier, a division of RELX India, Pvt. Ltd. All rights reserved.)
(Copyright © 2023 Cardiological Society of India. Published by Elsevier, a division of RELX India, Pvt. Ltd. All rights reserved.)